The trademark NEUTRIDERM was filed by UAS Pharmaceuticals Pty Ltd., a corporation established under the laws of the Commonwealth of Australia (the "Applicant"). The application was published for oppositions on August 6, 2020, and received undefined oppositions.
There are undefined Oppositions claimed against trademark.
The first opposition filed on November 8, 2020 by FINANCIERE BATTEUR on Likelihood of confusion. the opponent was represented by CABINET LE GUEN MAILLET and its proceedings were handled in English The second opposition filed on November 4, 2020 by LABORATORIO REIG JOFRE, S.A on Likelihood of confusion. the opponent was represented by SILEX IP and its proceedings were handled in English The third opposition filed on October 28, 2020 by KELITE S.r.l. on Likelihood of confusion. the opponent was represented by G.D. DI GRAZIA D'ALTO & C.S.N.C. and its proceedings were handled in English
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on September 8, 2021.
The Opposition with reference B 003134457 was refused according to Article 8(1)(b) EUTMR with decision issued on October 7, 2021 by the EUIPO.